{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T09:11:54Z","timestamp":1779354714399,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Technology Project of Guangzhou","award":["2024A03J1108"],"award-info":[{"award-number":["2024A03J1108"]}]},{"name":"Youth Medical Innovation and Practice Research Program of Guangzhou","award":["2023QNYXZD001"],"award-info":[{"award-number":["2023QNYXZD001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04346-y","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:24:01Z","timestamp":1776176641000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MTHFD1L in muscle invasive bladder cancer: a multi-cohort study on prognosis and therapeutic response"],"prefix":"10.1186","volume":"24","author":[{"given":"Siqiao","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peisheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Ya","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanru","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"issue":"3","key":"4346_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834. Epub 2024 Apr 4.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4346_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404\u201323. https:\/\/doi.org\/10.3322\/caac.21631. Epub 2020 Aug 7.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4346_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/JU.0000000000003981","volume":"212","author":"J Holzbeierlein","year":"2024","unstructured":"Holzbeierlein J, Bixler BR, Buckley DI, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA\/ASCO\/SUO guideline (2017; amended 2020, 2024). J Urol. 2024;212(1):3\u201310. https:\/\/doi.org\/10.1097\/JU.0000000000003981. Epub 2024 Apr 25.","journal-title":"J Urol"},{"key":"4346_CR4","doi-asserted-by":"publisher","first-page":"217339","DOI":"10.1016\/j.canlet.2024.217339","volume":"610","author":"M-S Jeong","year":"2025","unstructured":"Jeong M-S, Baek S-W, Yang G-E, et al. Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications. Cancer Lett. 2025;610:217339. https:\/\/doi.org\/10.1016\/j.canlet.2024.217339. Epub 2024 Nov 26.","journal-title":"Cancer Lett"},{"issue":"16","key":"4346_CR5","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","volume":"29","author":"G Griffiths","year":"2011","unstructured":"Griffiths G, Med Res Council Adv Bladder, C, Norwegian Bladder Canc Study, G, et al. International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial. J Clin Oncol. 2011;29(16):2171\u20137. https:\/\/doi.org\/10.1200\/JCO.2010.32.3139. Epub 2011 Apr 18.","journal-title":"J Clin Oncol."},{"issue":"4 Pt 1","key":"4346_CR6","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.juro.2015.10.133","volume":"195","author":"H Zargar","year":"2016","unstructured":"Zargar H, Zargar-Shoshtari K, Lotan Y, et al. Final pathological stage after neoadjuvant chemotherapy and radical cystectomy for bladder cancer-does pT0 predict better survival than pTa\/Tis\/T1? J Urol. 2016;195(4 Pt 1):886\u201393. https:\/\/doi.org\/10.1016\/j.juro.2015.10.133.","journal-title":"J Urol"},{"issue":"1","key":"4346_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01560-y","volume":"8","author":"Z Bai","year":"2025","unstructured":"Bai Z, Osman M, Brendel M, et al. Predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer via interpretable multimodal deep learning. NPJ Digit Med. 2025;8(1):174. https:\/\/doi.org\/10.1038\/s41746-025-01560-y.","journal-title":"NPJ Digit Med"},{"issue":"3","key":"4346_CR8","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","volume":"19","author":"JP Stein","year":"2001","unstructured":"Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666\u201375. https:\/\/doi.org\/10.1200\/JCO.2001.19.3.666.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4346_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","volume":"21","author":"M Yin","year":"2016","unstructured":"Yin M, Joshi M, Meijer RP, et al. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist. 2016;21(6):708\u201315. https:\/\/doi.org\/10.1634\/theoncologist.2015-0440.","journal-title":"Oncologist"},{"issue":"34","key":"4346_CR10","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1200\/JCO.18.01148","volume":"36","author":"A Necchi","year":"2018","unstructured":"Necchi A, Anichini A, Raggi D, et al. Pembrolizumab as neoadjuvant therapy before radical cystectomy in patients with muscle-invasive urothelial bladder carcinoma (PURE-01): an open-label, single-arm, phase II study. J Clin Oncol. 2018;36(34):3353\u201360. https:\/\/doi.org\/10.1200\/JCO.18.01148.","journal-title":"J Clin Oncol"},{"issue":"3","key":"4346_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.1215","volume":"7","author":"BA Maiorano","year":"2024","unstructured":"Maiorano BA, Di Maio M, Cerbone L, Maiello E, Procopio G, Roviello G. Significance of PD-L1 in metastatic urothelial carcinoma treated with immune checkpoint inhibitors. JAMA Netw Open. 2024;7(3):e241215. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.1215.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"4346_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2021.1887551","volume":"10","author":"L Guo","year":"2021","unstructured":"Guo L, Wang X, Wang S, Hua L, Song N, Hu B, et al. Efficacy of immune-checkpoint inhibitors in PD-L1 selected or unselected patients vs. control group in patients with advanced or metastatic urothelial carcinoma. Oncoimmunology. 2021;10(1):1887551. https:\/\/doi.org\/10.1080\/2162402X.2021.1887551.","journal-title":"Oncoimmunology"},{"issue":"7","key":"4346_CR13","doi-asserted-by":"publisher","first-page":"4612","DOI":"10.1074\/jbc.M109.079855","volume":"285","author":"ST Pike","year":"2010","unstructured":"Pike ST, Rajendra R, Artzt K, Appling DR. Mitochondrial C1-tetrahydrofolate synthase (MTHFD1L) supports the flow of mitochondrial one-carbon units into the methyl cycle in embryos. J Biol Chem. 2010;285(7):4612\u201320. https:\/\/doi.org\/10.1074\/jbc.M109.079855.","journal-title":"J Biol Chem"},{"issue":"2","key":"4346_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.abb.2005.08.007","volume":"442","author":"AS Walkup","year":"2005","unstructured":"Walkup AS, Appling DR. Enzymatic characterization of human mitochondrial C1-tetrahydrofolate synthase. Arch Biochem Biophys. 2005;442(2):196\u2013205. https:\/\/doi.org\/10.1016\/j.abb.2005.08.007.","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"4346_CR15","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/bjc.2017.118","volume":"116","author":"AC Newman","year":"2017","unstructured":"Newman AC, Maddocks ODK. One-carbon metabolism in cancer. Br J Cancer. 2017;116(12):1499\u2013504. https:\/\/doi.org\/10.1038\/bjc.2017.118.","journal-title":"Br J Cancer"},{"issue":"1","key":"4346_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2016.08.009","volume":"25","author":"GS Ducker","year":"2017","unstructured":"Ducker GS, Rabinowitz JD. One-carbon metabolism in health and disease. Cell Metab. 2017;25(1):27\u201342. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.009.","journal-title":"Cell Metab"},{"issue":"5","key":"4346_CR17","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1172\/JCI90253","volume":"127","author":"D Lee","year":"2017","unstructured":"Lee D, Xu I-J, Chiu D-C, et al. Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. J Clin Invest. 2017;127(5):1856\u201372. https:\/\/doi.org\/10.1172\/JCI90253.","journal-title":"J Clin Invest"},{"issue":"2","key":"4346_CR18","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20202063","volume":"41","author":"J Chen","year":"2021","unstructured":"Chen J, Yang J, Xu Q, et al. Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma. Biosci Rep. 2021;41(2):BSR20202063. https:\/\/doi.org\/10.1042\/BSR20202063.","journal-title":"Biosci Rep"},{"issue":"5","key":"4346_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/00365521.2017.1407440","volume":"53","author":"Y-S Yang","year":"2018","unstructured":"Yang Y-S, Yuan Y, Hu W-P, Shang Q-X, Chen L-Q. The role of mitochondrial folate enzyme MTHFD1L in esophageal squamous cell carcinoma. Scand J Gastroenterol. 2018;53(5):533\u201340. https:\/\/doi.org\/10.1080\/00365521.2017.1407440.","journal-title":"Scand J Gastroenterol"},{"key":"4346_CR20","doi-asserted-by":"publisher","first-page":"101869","DOI":"10.1016\/j.tice.2022.101869","volume":"77","author":"D Yi","year":"2022","unstructured":"Yi D, Yilihamu Ye, Jiang C, et al. MTHFD1L knockdown diminished cells growth in papillary thyroid cancer. Tissue Cell. 2022;77:101869. https:\/\/doi.org\/10.1016\/j.tice.2022.101869.","journal-title":"Tissue Cell"},{"issue":"11","key":"4346_CR21","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.tranon.2019.07.012","volume":"12","author":"M-L Eich","year":"2019","unstructured":"Eich M-L, Rodriguez Pena MdC, Shimoga Chandrashekar D, et al. Expression and role of methylenetetrahydrofolate dehydrogenase 1 like (MTHFD1L) in bladder cancer. Transl Oncol. 2019;12(11):1416\u201324. https:\/\/doi.org\/10.1016\/j.tranon.2019.07.012.","journal-title":"Transl Oncol"},{"issue":"6","key":"4346_CR22","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138. https:\/\/doi.org\/10.1038\/s41587-020-0546-8.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"4346_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang L-G, Han Y, He Q-Y. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"issue":"7","key":"4346_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"4346_CR25","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25(2):152\u201365. https:\/\/doi.org\/10.1016\/j.ccr.2014.01.009.","journal-title":"Cancer Cell"},{"issue":"1","key":"4346_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-66747-7","volume":"10","author":"CC Guo","year":"2020","unstructured":"Guo CC, Bondaruk J, Yao H, et al. Assessment of luminal and basal phenotypes in bladder cancer. Sci Rep. 2020;10(1):9743. https:\/\/doi.org\/10.1038\/s41598-020-66747-7.","journal-title":"Sci Rep"},{"issue":"5","key":"4346_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.eururo.2021.10.035","volume":"81","author":"G Sjodahl","year":"2022","unstructured":"Sjodahl G, Abrahamsson J, Holmsten K, et al. Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypes. Eur Urol. 2022;81(5):523\u201332. https:\/\/doi.org\/10.1016\/j.eururo.2021.10.035.","journal-title":"Eur Urol"},{"issue":"1","key":"4346_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-023-05615-3","volume":"24","author":"C Liao","year":"2023","unstructured":"Liao C, Wang X. Tcgaplot: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data. BMC Bioinformatics. 2023;24(1):483. https:\/\/doi.org\/10.1186\/s12859-023-05615-3.","journal-title":"BMC Bioinformatics"},{"issue":"21","key":"4346_CR29","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.1093\/bioinformatics\/btz229","volume":"35","author":"CS Groeneveld","year":"2019","unstructured":"Groeneveld CS, Chagas VS, Jones SJM, et al. Rtnsurvival: an R\/Bioconductor package for regulatory network survival analysis. Bioinformatics. 2019;35(21):4488\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btz229.","journal-title":"Bioinformatics"},{"key":"4346_CR30","doi-asserted-by":"publisher","unstructured":"Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024;19:3292-320. https:\/\/doi.org\/10.1038\/s41596-024-01020-z.","DOI":"10.1038\/s41596-024-01020-z"},{"key":"4346_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","author":"S Haenzelmann","year":"2013","unstructured":"Haenzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinformatics"},{"key":"4346_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216739","volume":"588","author":"W Yin","year":"2024","unstructured":"Yin W, Chen G, Li Y, et al. Identification of a 9-gene signature to enhance biochemical recurrence prediction in primary prostate cancer: a benchmarking study using ten machine learning methods and twelve patient cohorts. Cancer Lett. 2024;588:216739. https:\/\/doi.org\/10.1016\/j.canlet.2024.216739.","journal-title":"Cancer Lett"},{"issue":"2","key":"4346_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3892\/or.2020.7890","volume":"45","author":"Z Guo","year":"2021","unstructured":"Guo Z, Zhang X, Zhu H, et al. TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2. Oncol Rep. 2021;45(2):523\u201334. https:\/\/doi.org\/10.3892\/or.2020.7890. Epub 2020 Dec 9.","journal-title":"Oncol Rep"},{"issue":"11","key":"4346_CR34","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin D-C, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","journal-title":"Genome Res"},{"issue":"10","key":"4346_CR35","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, et al. Signatures of T-cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"key":"4346_CR36","doi-asserted-by":"publisher","unstructured":"Liu X, Wang F, Cui P, Zheng Z, Zhang N, Kong R. Focal adhesion kinase inhibition enhances response to checkpoint immunotherapy in hepatocellular carcinoma. J Transl Int Med. 2025;14(1):64-78. https:\/\/doi.org\/10.1515\/jtim-2025-0051.","DOI":"10.1515\/jtim-2025-0051"},{"issue":"3","key":"4346_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X, et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. Imeta. 2022;1(3):e36. https:\/\/doi.org\/10.1002\/imt2.36.","journal-title":"Imeta"},{"issue":"1","key":"4346_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01200-4","volume":"14","author":"W Yu","year":"2021","unstructured":"Yu W, Lei Q, Yang L, et al. Contradictory roles of lipid metabolism in immune response within the tumor microenvironment. J Hematol Oncol. 2021;14(1):187. https:\/\/doi.org\/10.1186\/s13045-021-01200-4.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"4346_CR39","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.71321\/lcflx.00001","volume":"1","author":"J Cheng","year":"2024","unstructured":"Cheng J, He Z, Jing J, Liu Y, Zhang H. Integrating machine learning and multi-omics to identify key SUMOylation molecular signature in sarcoma. Life Conflux. 2024;1(1):e88. https:\/\/doi.org\/10.71321\/lcflx.00001.","journal-title":"Life Conflux."},{"key":"4346_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217887","volume":"630","author":"E Zhang","year":"2025","unstructured":"Zhang E, Ding X, Zhang J, et al. Multi-omics analysis of polyamine metabolism implicates NT5E\/CD73 in the progression of pancreatic cancer. Cancer Lett. 2025;630:217887. https:\/\/doi.org\/10.1016\/j.canlet.2025.217887.","journal-title":"Cancer Lett"},{"key":"4346_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/mdr2.70010","author":"X Wang","year":"2025","unstructured":"Wang X, Li J, Ning J. Comprehensive multi\u2010omics integration reveals B cell\u2010derived ELL2 as a novel diagnostic and prognostic biomarker in Sepsis. Med Research. 2025. https:\/\/doi.org\/10.1002\/mdr2.70010.","journal-title":"Med Research"},{"issue":"44","key":"4346_CR42","doi-asserted-by":"publisher","first-page":"43178","DOI":"10.1074\/jbc.M304319200","volume":"278","author":"P Prasannan","year":"2003","unstructured":"Prasannan P, Pike S, Peng K, Shane B, Appling DR. Human mitochondrial C1-tetrahydrofolate synthase: gene structure, tissue distribution of the mRNA, and immunolocalization in Chinese hamster ovary calls. J Biol Chem. 2003;278(44):43178\u201387. https:\/\/doi.org\/10.1074\/jbc.M304319200.","journal-title":"J Biol Chem"},{"issue":"2","key":"4346_CR43","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1073\/pnas.1211199110","volume":"110","author":"J Momb","year":"2013","unstructured":"Momb J, Lewandowski JP, Bryant JD, et al. Deletion of Mthfd1l causes embryonic lethality and neural tube and craniofacial defects in mice. Proc Natl Acad Sci U S A. 2013;110(2):549\u201354. https:\/\/doi.org\/10.1073\/pnas.1211199110.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4346_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00326-0","volume":"5","author":"H-Q Ju","year":"2020","unstructured":"Ju H-Q, Lin J-F, Tian T, Xie D, Xu R-H. Nadph homeostasis in cancer: functions, mechanisms and therapeutic implications. Signal Transduct Target Ther. 2020;5(1):231. https:\/\/doi.org\/10.1038\/s41392-020-00326-0.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4346_CR45","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211783","volume":"42","author":"N Sial","year":"2022","unstructured":"Sial N, Rehman JU, Saeed S, et al. Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human cancers. Biosci Rep. 2022;42(1):BSR20211783. https:\/\/doi.org\/10.1042\/BSR20211783.","journal-title":"Biosci Rep"},{"issue":"14","key":"4346_CR46","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.7150\/jca.35014","volume":"11","author":"Z He","year":"2020","unstructured":"He Z, Wang X, Zhang H, et al. High expression of folate cycle enzyme MTHFD1L correlates with poor prognosis and increased proliferation and migration in colorectal cancer. J Cancer. 2020;11(14):4213\u201321. https:\/\/doi.org\/10.7150\/jca.35014.","journal-title":"J Cancer"},{"issue":"6","key":"4346_CR47","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/10799893.2020.1769658","volume":"40","author":"L Wang","year":"2020","unstructured":"Wang L, Yang Y, Wang X-M, Wang C-Q, Zhang Y-M, Li B-L. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the AKT\/mTOR pathway. J Recept Signal Transduct Res. 2020;40(6):584\u201390. https:\/\/doi.org\/10.1080\/10799893.2020.1769658.","journal-title":"J Recept Signal Transduct Res"},{"issue":"1","key":"4346_CR48","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","volume":"32","author":"J Liu","year":"2022","unstructured":"Liu J, Peng Y, Wei W. Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends Cell Biol. 2022;32(1):30\u201344. https:\/\/doi.org\/10.1016\/j.tcb.2021.07.001.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"4346_CR49","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.semcancer.2013.01.001","volume":"23","author":"N Donley","year":"2013","unstructured":"Donley N, Thayer MJ. DNA replication timing, genome stability and cancer. Semin Cancer Biol. 2013;23(2):80\u20139. https:\/\/doi.org\/10.1016\/j.semcancer.2013.01.001.","journal-title":"Semin Cancer Biol"},{"key":"4346_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-012414-040424","volume":"10","author":"M Macheret","year":"2015","unstructured":"Macheret M, Halazonetis TD. DNA replication stress as a hallmark of cancer. Annu Rev Pathol. 2015;10:425\u201348. https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040424.","journal-title":"Annu Rev Pathol"},{"key":"4346_CR51","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31132","volume":"6","author":"X Zhang","year":"2017","unstructured":"Zhang X, Saarinen AM, Hitosugi T, et al. Inhibition of intracellular lipolysis promotes human cancer cell adaptation to hypoxia. Elife. 2017;6:e31132. https:\/\/doi.org\/10.7554\/eLife.31132.","journal-title":"Elife"},{"issue":"1","key":"4346_CR52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/cdd.2017.171","volume":"25","author":"AM Kaiser","year":"2018","unstructured":"Kaiser AM, Attardi L. Deconstructing networks of p53-mediated tumor suppression in vivo. Cell Death Differ. 2018;25(1):93\u2013103. https:\/\/doi.org\/10.1038\/cdd.2017.171.","journal-title":"Cell Death Differ"},{"issue":"10","key":"4346_CR53","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine AJ, Oren M. The first 30 years of p53: growing ever more complex. Nat Rev Cancer. 2009;9(10):749\u201358. https:\/\/doi.org\/10.1038\/nrc2723.","journal-title":"Nat Rev Cancer."},{"issue":"5","key":"4346_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18050961","volume":"18","author":"M Ferraiuolo","year":"2017","unstructured":"Ferraiuolo M, Verduci L, Blandino G, Strano S. Mutant p53 protein and the Hippo transducers YAP and TAZ: a critical oncogenic node in human cancers. Int J Mol Sci. 2017;18(5):961. https:\/\/doi.org\/10.3390\/ijms18050961.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"4346_CR55","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3724\/abbs.2025008","volume":"57","author":"H Chen","year":"2025","unstructured":"Chen H, Shan J, Qi W, Chen L, Zeng X. P53-dependent chromatin relaxation is required for DNA double-strand break repair. Acta Biochim Biophys Sin. 2025;57(5):701\u201311. https:\/\/doi.org\/10.3724\/abbs.2025008.","journal-title":"Acta Biochim Biophys Sin"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04346-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04346-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04346-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:51:02Z","timestamp":1779353462000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04346-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4346"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04346-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"10 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}